Related references
Note: Only part of the references are listed.Clinical features and biological implications of different U2AF1 mutation types in myelodysplastic syndromes
Bing Li et al.
GENES CHROMOSOMES & CANCER (2018)
Prognostic significance of ASXL1 mutation types and allele burden in myelofibrosis
A. Tefferi et al.
LEUKEMIA (2018)
Insights from structures of cancer-relevant pre-mRNA splicing factors
Clara L. Kielkopf
CURRENT OPINION IN GENETICS & DEVELOPMENT (2018)
Revised cytogenetic risk stratification in primary myelofibrosis: analysis based on 1002 informative patients
Ayalew Tefferi et al.
LEUKEMIA (2018)
The U2AF1S34F mutation induces lineage-specific splicing alterations in myelodysplastic syndromes
Bon Ham Yip et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Spliceosomal gene mutations in myelodysplasia: molecular links to clonal abnormalities of hematopoiesis
Daichi Inoue et al.
GENES & DEVELOPMENT (2016)
Therapeutic targeting of splicing in cancer
Stanley Chun-Wei Lee et al.
NATURE MEDICINE (2016)
Targeted deep sequencing in primary myelofibrosis
Ayalew Tefferi et al.
BLOOD ADVANCES (2016)
U2AF1 mutations alter splice site recognition in hematological malignancies
Janine O. Ilagan et al.
GENOME RESEARCH (2015)
U2AF1 mutations in primary myelofibrosis are strongly associated with anemia and thrombocytopenia despite clustering with JAK2V617F and normal karyotype
A. Tefferi et al.
LEUKEMIA (2014)
Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progression
Shang-Ju Wu et al.
AMERICAN JOURNAL OF HEMATOLOGY (2013)
Spliceosome mutations involving SRSF2, SF3B1, and U2AF35 in chronic myelomonocytic leukemia: Prevalence, clinical correlates, and prognostic relevance
Mrinal M. Patnaik et al.
AMERICAN JOURNAL OF HEMATOLOGY (2013)
Mutations and prognosis in primary myelofibrosis
A. M. Vannucchi et al.
LEUKEMIA (2013)
SF3B1 mutations in primary myelofibrosis: clinical, histopathology and genetic correlates among 155 patients
T. L. Lasho et al.
LEUKEMIA (2012)
A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)
Francesco Passamonti et al.
BLOOD (2010)
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
James W. Vardiman et al.
BLOOD (2009)
Share Paper
